4 RNA Therapeutics Stocks Leading the Next Wave of InnovationZacks2026. 09. 28. 22:57
Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy PlatformMarketBeat2026. 09. 25. 12:02
CoreWeave upgraded, Etsy downgraded: Wall Street's top analyst callsThe Fly2026. 09. 24. 22:41
Citigroup Upgrades Arcturus Therapeutics to Buy From Neutral, Adjusts PT to $20 From $8MT Newswires2026. 09. 24. 19:35
Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery PlatformBusiness Wire2026. 09. 24. 05:01
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics PlatformBusiness Wire2026. 09. 18. 22:00

조회 2026. 10. 12. 10:07 · KST